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Abstract
Background: Accumulated to-date gene microarray data on Acute Respiratory Distress Syndrome (ARDS) in the
Gene Expression Omnibus (GEO) represent a rich source for identifying new unsuspected targets and mechanisms
of ARDS. The recently developed expression-based genome-wide association study (eGWAS) for analysis of GEO
data was successfully used for analysis of gene expression of comparatively noncomplex adipose tissue, 75 % of
which is represented by adipocytes. Although lung tissue is more heterogenic and does not possess a prevalent
cell type for driving gene expression patterns, we hypothesized that eGWAS of ARDS samples will generate
biologically meaningful results.
Methods: The eGWAS was conducted according to (Proc Natl Acad Sci U S A 109:7049-7054, 2012) and genes were
ranked according to p values of chi-square test.
Results: The search of GEO retrieved 487 ARDS related entries. These entries were filtered for multiple qualitative
and quantitative conditions and 219 samples were selected: mouse nsham/ARDS = 67/92, rat n = 13/13, human cells
n = 11/11, canine n = 6/6 with the following ARDS model distributions: mechanical ventilation (MV)/cyclic stretch
n = 11; endotoxin (LPS) treatment n = 8; MV + LPS n = 3; distant organ injury induced ARDS n = 3; chemically
induced ARDS n = 2; Staphylococcus aureus induced ARDS n = 2; and one experiment each for radiation and shock
induced ARDS. The eGWAS of this dataset identified 42 significant (Bonferroni threshold P < 1.55 × 10−6) genes.
66.6 % of these genes, were associated previously with lung injury and include the well known ARDS genes such as
IL1R2 (P = 4.42 × 10−19), IL1β (P = 3.38 × 10−17), PAI1 (P = 9.59 × 10−14), IL6 (P = 3.57 × 10−12), SOCS3 (P = 1.05 × 10−10),
and THBS1 (P = 2.01 × 10−9). The remaining genes were new ARDS candidates. Expression of the most prominently
upregulated genes, CLEC4E (P = 4.46 × 10−14) and CD300LF (P = 2.31 × 10−16), was confirmed by real time PCR. The
former was also validated by in silico pathway analysis and the latter by Western blot analysis.
Conclusions: Our first in the field application of eGWAS in ARDS and utilization of more than 120 publicly available
microarray samples of ARDS not only justified applicability of eGWAS to complex lung tissue, but also discovered 14
new candidate genes which associated with ARDS. Detailed studies of these new candidates might lead to
identification of unsuspected evolutionarily conserved mechanisms triggered by ARDS.
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Background
Acute Respiratory Distress Syndrome (ARDS) is a devas-
tating illness associated with systemic inflammatory re-
sponse to infection or severe injury [1]. Sepsis, trauma,
shock, surgery and other causes of systemic inflamma-
tion can lead to ARDS. The clinical presentation of
ARDS is characterized by profuse pulmonary edema,
acute lung inflammation with recruitment of neutrophils
and disruption of the alveolar-capillary barrier. Several
studies by our group replicated these characteristics of
ARDS in both cell culture (cyclic stretch) and rodent
models (mechanical ventilation, endotoxin (LPS) treat-
ment, and ARDS induced by kidney ischemia reperfu-
sion injury) [2, 3]. The role of inflammation in ARDS
has typically been studied in relation to either infection
and sepsis or trauma and visceral organ injury. Although
progress has been made in the understanding of ARDS
etiologies, there is pausity of studies that focus on com-
mon responses of the lung to both septic and aseptic
challenges.
While in the last decade, a large amount of data from
different models of ARDS was collected and became
available to the scientific community, the systematic ana-
lysis of this remarkable data substrate was not actively
conducted. Therefore, we intended to analyze this big
data using newly developed expression-based genome-
wide association studies (eGWAS), which was tested
successfully on adipose tissue [4]. However, the majority
of cells in adipose tissue is represented by adipocytes
(75 %), with the other 25 % shared between vasculature
and connective tissue [5]. The lung alveolar tissue on
the other hand does not have a prevalent cell type,
which might drive the transcriptional response to an in-
jury, and is comprised of type I epithelial cells (8 %), al-
veolar macrophages (9 %), type II epithelial cells (16 %),
capillary endothelial cells (30 %), and cells of the intersti-
tial space (37 %) [6].
Therefore, we hypothesized that despite variable con-
tribution to gene expression by different alveolar cell
types, eGWAS will be efficient for the analysis of the
transcriptional response by lung tissue to an injury. To
test this hypothesis we collected and simultaneously ana-




The ARDS datasets were collected from Gene Expression
Omnibus (GEO, NCBI, (http://www.ncbi.nlm.nih.gov/geo)
public functional genomics data repository. The GEO
database was searched for “acute lung injury,” which
returned 60 hits, and “lung injury,” which returned 487
hits (as of September 2014). Most of these entries were in-
dividual samples that duplicated samples, which were
already combined into existing data sets. The elimination
of these duplicates reduced the obtained data to 48 sets
(Additional file 1: Table S1). These sets were further fil-
tered down to 31 data sets using the following criteria:
Fig. 1 eGWAS of combined 8 ARDS models. The plot depicts chi-square P values (−log10) on the y axis arranged by chromosomal location (x axis).
P values for each gene were calculated for 97 sham-operated or vehicle exposed control microarray samples and 122 ARDS microarray samples
as the likelihood of finding repeated differential expression compared with expected using χ2 analysis. Out of 32160 tested gene entries, 42 genes
demonstrated a significant differential expression. The dashed line indicates the Bonferroni threshold (P = 1.55 × 10−6). The gene symbols indicate
known ARDS genes that are most significantly associated with ARDS throughout all tested models, where underscored symbols indicate new
candidate genes
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1) the array samples must represent genome wide studies
by the established microarray platforms with the number
of interrogated sequences >5000, thus excluding custom
platforms designed for a specific organ or pathway, which
introduces tissue or biological process bias; 2) the experi-
mental settings must contain untreated (either placebo or
sham) and unmodified (wild type) subjects; 3) biological
replicate n ≥ 3 per each sham or experimental group; 4)
proper signal distribution as identified by the significance
of microarray (SAM) plot.
Authors believe that all data uploaded from GEO in-
volving human subjects have been obtained with the ap-
proval of appropriate ethics committees by Silva et al.
and Eltzschig et al. (Additional file 1: Table S1).
Expression-based genome-wide association study (eGWAS)
The eGWAS was conducted as described previously [4].
Briefly, to estimate differences between groups of samples
from ARDS subjects and sham controls, raw postquantita-
tion microarray data were reanalyzed by SAM 2.0 soft-
ware. Then the P values from the number of positive/
negative experiments for each gene and sum of the num-
ber of positive/negative experiments for all other genes
were calculated using a 2 × 2 chi-square or a Fisher’s exact
test. The probe IDs across different microarray platforms
for mouse, rat, and human were linked using the array in-
formation library universal navigator (AILUN) tool (http://
ailun.stanford.edu). The probes that remained unmatched
by the AILUN tool were linked to the AILUN created
mouse-rat-human dataset via their gene symbol entries.
Given that canine and human samples were represented
by only 1 and 2 experiments, respectively the species-
related weighting algorithm [7] was not applicable.
Pathway analysis
The pathway analysis, which identifies the most relevant
biological processes to a specific list of candidate genes,
was conducted using the Ingenuity Pathways Knowledge
Base tool (IPA, Ingenuity Systems, Inc., Redwood City,
CA.) as described previously [3].
Automated literature search
PubMatrix (multiplex literature mining tool) analysis was
conducted as described previously [7]. We restricted our
search to human symbols approved by HUGO Gene No-
menclature Committee (HGNC), which were enriched by
all aliases and former (discontinued) symbols for selected
candidate genes (http://www.genenames.org).
Cecal ligation and puncture model
All mouse experiments were approved by the University of
Missouri Kansas City Institutional Animal Care and User
Committee. To confirm the unversal nature of the response
to the ARDS stimuli by our candidates, we employed the
Table 1 PubMatrix analysis
Symbol Lung Lung injury Acute lung injury
IL1R2 11 3 1
IL1B 59 11 4
CLEC4D 1 1 0
CD300LF 0 0 0
CLEC4E 1 0 0
PAI1 548 159 91
LILRB4 4 0 0
S100A9 88 8 2
CCR1 84 10 6
CXCL2 600 250 134
IL6 332 55 24
PLAUR 146 16 6
CCRN4L 0 0 0
CH25H 3 0 0
NFIL3 2 1 1
S100A8 96 12 6
MMP8 20 5 4
SOCS3 82 15 8
BCL3 2 1 1
MAFF 3 0 0
THBS1 140 12 1
RHOU 3 0 0
CXCL3 13 3 2
GADD45G 10 0 0
SPHK1 32 6 0
SAMSN1 3 0 0
ZFP36 11 0 0
CXCL1 458 163 91
CDKN1A 714 35 5
ARG2 23 1 0
CCL3 305 54 26
JUNB 55 3 0
PLA2G7 2 0 0
ARID5A 0 0 0
SLPI 184 28 10
APOLD1 1 0 0
CSF2RB 18 1 0
FPR2 42 6 4
ADM 440 21 8
OSMR 7 0 0
TREM1 39 21 3
TNFAIP3 16 5 3
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mouse septic model - cecal ligation and puncture (CLP),
which was not present in the GEO data collection
(Additional file 1: Table S1). We selected the most com-
monly used time point (24 h after injury) for the CLP septic
model [8]. Animals (n= 6) were anesthetized and laparot-
omy performed. The cecum was exposed and ligated. In
three mice, the cecum was punctured twice using 16G
needle and then squeezed to extrude contents in a 2 mm of
fecal amount. Mice (n = 3) without the puncture were used
as controls (shams). Wounds were closed. After 24 h mice
were sacrificed and the lungs were collected for histological,
real-time RT-PCR, and Western blot studies. All mouse
experiments were approved by the University of Missouri
Kansas City Institutional Animal Care and User Committee.
Histological studies and Real-time RT-PCR
For histological studies, lungs were perfused first with
PBS followed by 4 % paraformaldehyde, and then em-
bedded in paraffin. 5 μm thick slices were prepared and
stained with H&E according to standard protocol.
The real time PCR of mRNAs extracted from lung tissue
was conducted as previously described [7]. Slight modifi-
cations were made according to the manufacturer’s new
protocol. Briefly, the 384-well microtiter plate setting of a
ViiA™ 7 Real-Time PCR System (Applied Biosystems) was
employed. TaqMan® Predeveloped Assay Reagent mouse
β-actin (REF 435234E, probe dye VIC-MGB) was used as
an internal control for normalization. TaqMan® Gene Ex-
pression assay for mouse Clec4e and Cd300lf were pur-
chased from Applied Biosystems Inc. (Mm 01183703_m1
and Mm 00467508_m1, respectively). All experimental
protocols were based on manufactures’ recommendation
using the TaqMan® Universal Master Mix II (P/N
4440039). A relative quantitative method was used to cal-
culate corresponding transcript levels relative to actin
expression. The significance of the obtained differ-
ence in signal between sham and CLP mice was
assessed using t-tests where p < 0.05 was considered
significant.
Western blotting
Immediately after euthanizing the mice, the lungs were
perfused with PBS prior to tissue proteins extraction with
lysis buffer. Protein concentration was determined by
BCA assay (Thermo Scientific, prod # 23227). Equal total
proteins (20 μg) for each lung cell lysate sample were ana-
lyzed by SDS-PAGE followed by Western blotting on
PVDF membrane. Anti-CD300LF (Proteintech Group,
Inc, cat# 13334-1-AP) antibody was used. Monoclonal
anti-actin antibody (Santa Cruz, cat. # SC-47778) was
used as a loading control. Protein signal was revealed by
FluorChem M chemiluminescence (Proteinsimple™).
Results and discussion
The search of the GEO repository returned submissions
related to lung injury from the past 8 years with a total
of 487 samples of in vivo and in vitro models of ARDS,
which covered the most common biological experimen-
tal models: rodent, canine, and cultures of human cells.
The filtering for inclusion criteria outlined in Materials
and Methods retained a total of 97 control and 122
ARDS samples: mouse nsham/ARDS = 67/92, rat n = 13/13,
human cells n = 11/11, canine n = 6/6. All these samples
were derived from 31 in vivo and in vitro experimental
settings (ES) that were grouped into 8 common
models: 1) mechanical ventilation (MV)/cyclic stretch
ES = 11; 2) LPS treatment ES = 8; 3) MV + LPS ES = 3;
4) distant organ injury induced ARDS ES = 3; 5)
A CB




















Fig. 2 Histopathology of CLP affected lungs and expression pattern of novel ARDS candidate genes. Panels a-b: Light micrographs of H&E stained
lung sections from sham (a) and CLP (b) mice. The lung histopathology in CLP-challenged mice demonstrates broadening of alveolar septa with
sparse monocyte infiltration (arrowheads) and hemorrhage in septa (arrow). Original magnification, 200×. Panel c: The expression of Clec4e and
Cd300lf genes in whole mouse lung is represented by horizontal bars. The error bars are standard deviations among three samples. The real time
PCR was conducted using commercially available TaqManTM reactions
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chemically induced ARDS ES = 2; 6) Staphylococcus
aureus induced ARDS ES = 2; and one experiment for
each 7) radiation and 8) shock induced ARDS (Additional
file 1: Table S1).
Cross-referencing of these microarrays resulted in a
dataset of 32160 gene entries. eGWAS analysis ranked
these genes first by the likelihood that repeated differen-
tial expression for a given gene was due to chance, then
controlled for multiple-hypothesis testing using Bonfer-
roni threshold (P < 1.55 × 10−6), which identified 42 can-
didate genes (Fig. 1, Additional file 2: Table S2).
To identify relevance of our candidates to ARDS, we
linked 42 genes to 3 terms: “lung”, “lung injury”, and
“acute lung injury” using the PubMatrix tool. This ap-
proach identified 23 candidates (54.7 %) as previously
linked to ARDS genes (at least one citation with the
term “acute lung injury”), which justifies the suitability
of eGWAS for the analysis of lung injury (Table 1). The
actual Score(d) and fold changes for these genes in each
model can be found in Additional file 3: Table S3.
This approach also identified 5 novel genes (at least
one citation with the term “lung injury”) and 14 new
genes (0 links to “lung injury”). Surprisingly, among the
top five genes identified in our study to be associated
with ARDS, only IL1R2 and IL1B were known ARDS










Sham CLP CLP 
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Fig. 3 In silico and in vitro validation of Clec4e and Cd300lf gene candidates. Panel a: The top gene network generated by IPA for 42 ARDS gene
candidates. This network was reduced to genes that posses at least three established connections to members of the network. Relationships
between genes are represented by solid lines (binding), solid arrows (direct activation), or broken arrows (indirect activation). Arrows point to the
element on which an action is performed. Black molecules represent new candidate genes. Grey molecules represent significant ARDS genes.
Panel b: The Western blot analysis of Cd300lf protein expression. Each lane contains 20 μg of lung tissue lysate. The top bands represent signals
of Cd300lf protein in the sham and two CLP challenged mice. The bottom bands represent signals of actin, which was used as a loading control
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lectin domain family 4, member D CLEC4D gene [9]
and new genes CD300 molecule-like family member F
(CD300LF) [10] and C-type lectin domain family 4,
member E (CLEC4E) [11] (Fig. 1 and Table 1).
To confirm the commonality of expressional changes
of our candidates to the ARDS stimuli we utilized a CLP
septic model, which was not present among the models
obtained from GEO (Additional file 1: Table S1). The
histological study of this additional model confirmed the
acute injury to lung tissue (Fig. 2a and 2b). Real-time
PCR analysis of Cd300lf and Clec4e expression in the
CLP model demonstrated upregulation of both genes
(Fig. 2c), similar to that detected by eGWAS.
Interactive network analysis of 42 candidates incor-
porated one of our candidates, CLEC4E, into the net-
work of the well-known ARDS genes (Fig. 3a), thus
indirectly validating involvement of this gene in the
pathogenesis of ARDS. Indeed, this gene can be a po-
tential biomarker for ARDS. CLEC4E is expressed in
activated macrophages and codes for a cell-surface re-
ceptor, which recognizes a wide variety of ligands in-
cluding damaged cells, fungi and mycobacteria [12].
Moreover, there is a recent report on the protective
role of CLEC4E in sepsis caused by K. pneumonia [13],
moreover, CLEC4E binds to another lung specific
microorganism Streptococcus pneumoniae [14]. These
reports indirectly link our new candidate to the lung
pathology and warrant the new studies of this gene in
the ARDS settings.
Our next candidate, CD300LF, codes for an inhibitory
receptor of the Ig superfamily of myeloid cells. To con-
firm the significance of CD300LF expression, we mea-
sured its protein expression by Western blot analysis,
which confirmed upregulation of our candidate (Fig. 3b).
There are no reports on the potential link of CD300LF
to a lung pathology, however it has been shown that
upregulation of this gene has a protective role in acute
brain injury [15], therefore it will be enticing to investi-
gate whether upregulation of this candidate will play a
similar protective role in acute lung injury.
Conclusions
In the present study, we investigated molecular signatures
of 8 ARDS models in four different biological systems
(mouse, rat, dog, and human) using eGWAS. eGWAS
identified 42 ARDS candidate genes, two-thirds of which
was previously linked to lung injury, which justifies the
eGWAS utility for investigating differential gene expres-
sion in complex tissues.
Our first in the field exploration of ARDS using eGWAS
of 120 microarray samples of lung injury identified 14 new
molecular targets common to different species and models,
suggesting new players in the evolutionarily conserved
mechanisms triggered during ARDS. These findings will
guide further research in the field of molecular targeting of
ARDS and will open new unsuspected avenues for transla-
tional research. We expect that further studies of our
newly discovered candidates will lead to the development
of new biomarkers for ARDS.
Additional files
Additional file 1: Table S1. Detailed representation of data obtained
from GEO. ARDS gene expression submissions were retrieved from GEO
using two terms “Acute lung injury” and “Lung injury”, which resulted in
23 and 25 data sets, respectively. These 48 entries were filtered down to
31 entries according to conditions described in Methods. The reason for
filtering out an experiment is provided. (XLSX 16 kb)
Additional file 2: Table S2. Chi-square values of cross-referenced genes.
Given that different microarray platforms have multiple probes for a
single gene, the cross-referencing of such platforms generates numerous
combinations of expression values for a given gene (32160 in this study).
Chi-square value was calculated for each of these combinations and
combination with the best chi-square value for a given gene was retained,
which resulted in 3152 unique gene entries. These genes were linked to
human genome and plotted against their location (Fig. 1). (XLS 185 kb)
Additional file 3: Table S3. Contribution of each ARDS model to the
overall gene expression signal of an ARDS gene candidate. Each dataset
obtained from GEO was reanalyzed using SAM 2.0. The d-score and fold
change values for 42 gene candidates were extracted from SAM 2.0
outputs and reported according to the ARDS model. (XLSX 45 kb)
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